Patent application number | Description | Published |
20130217124 | MODIFIED SILICA SHELL PARTICLES, AND METHODS OF MAKING AND USING THE SAME - Provided herein are silica shell particles modified on their surface with biomolecules, methods of making these particles, and methods of using these particles, e.g., in transfection methods, methods of inhibiting gene expression, and methods of delivering a therapeutic. | 08-22-2013 |
20130217180 | Low-Temperature Fabrication of Metal Oxide Thin Films and Nanomaterial-Derived Metal Composite Thin Films - Disclosed are new methods of fabricating metal oxide thin films and nanomaterial-derived metal composite thin films via solution processes at low temperatures (<400° C.). The present thin films are useful as thin film semiconductors, thin film dielectrics, or thin film conductors, and can be implemented into semiconductor devices such as thin film transistors and thin film photovoltaic devices. | 08-22-2013 |
20130222303 | HAPTIC DEVICE WITH INDIRECT HAPTIC FEEDBACK - A haptic device provides indirect haptic feedback and includes a substrate having a touch surface, a position sensor and a friction modulator associated with the substrate, wherein a coefficient of friction of the touch surface is modulated in response to a sensed position of relative to the touch surface and/or a derivative thereof. | 08-29-2013 |
20130224633 | NANOSTRUCTURED CARBON ELECTRODE, METHODS OF FABRICATING AND APPLICATIONS OF THE SAME - Nanostructured carbon electrode usable for electrochemical devices and methods of fabricating the same. The method of fabricating a nanostructured carbon electrode includes providing a carbon material of large-effective-surface-area polyaromatic hydrocarbon (LPAH), mixing the carbon material of LPAH with a surfactant in a solution to form a suspension thereof; depositing the suspension onto a substrate to form a layered structure; and sintering the layered structure at a temperature for a period of time to form a nanostructured carbon electrode having a film of LPAH. | 08-29-2013 |
20130224747 | Pathogenecity Islands of Pseudomonas Aeruginosa - Disclosed are | 08-29-2013 |
20130226232 | IMPROVED SUTURE - A medical device includes a surgical needle attached to a hollow tubular suture. The suture is constructed of macroporous hollow tubular wall that facilitates and allows tissue integration into the suture core subsequent to introduction to the body, thereby preventing suture pull-through and improving biocompatibility. | 08-29-2013 |
20140020745 | METAL OXIDE-ENCAPSULATED DYE-SENSITIZED PHOTOANODES FOR DYE-SENSITIZED SOLAR CELLS - Dye-sensitized semiconducting metal oxide films for photoanodes, photoanodes incorporating the films and DSCs incorporating the photoanodes are provided. Also provided are methods for making the dye sensitized semiconducting metal oxide films. The methods of making the films are based on the deposition of an encapsulating layer of a semiconducting metal oxide around the molecular anchoring groups of photosensitizing dye molecules adsorbed to a porous film of the semiconducting metal oxide. The encapsulating layer of semiconducting metal oxide is formed in such a way that it is not coated over the chromophores of the adsorbed dye molecules and, therefore, allows the dye molecules to remain electrochemically addressable. | 01-23-2014 |
20140037545 | INHIBITION OF FIBROSIS AND AF BY TGF-BETA INHIBITION IN THE POSTERIOR LEFT ATRIUM (PLA) - The disclosed methods pertain to diagnosing whether a non-ablative, gene therapy is needed for reducing AF fibrosis in a subject, and if so, methods of reducing AF fibrosis in a subject using gene therapy with a dominant negative TGF-β R2 cDNA expression vector. Kits and computer program products are also described, wherein the kits provide materials for diagnosing and treating AF fibrosis, and the computer program products include a computer readable medium having computer readable program code for monitoring the efficacy of therapeutic ablation of fibrosis in a subject using a gene therapy method. | 02-06-2014 |
20140037749 | Delivery Scaffolds and Related Methods of Use - The present invention relates to delivery systems. In particular, the present invention provides microporous scaffolds having thereon agents (e.g., extracellular matrix proteins, exendin-4) and biological material (e.g., pancreatic islet cells). In some embodiments, the scaffolds are used for transplanting biological material into a subject. In some embodiments, the scaffolds are used in the treatment of diseases (e.g., type 1 diabetes), and related methods (e.g., diagnostic methods, research methods, drug screening). | 02-06-2014 |